Esomeprazole Side Effects: What You Need to Know

Esomeprazole is a proton pump inhibitor (PPI) and is one of the most widely prescribed medicines in the UK. For most people, it is well tolerated, particularly during short-term use (4 to 8 weeks).

Common side effects (affecting more than 1 in 100 people):

• Headache: the most frequently reported side effect, usually mild
• Abdominal pain: may include stomach cramps, bloating or discomfort
• Diarrhoea: typically mild and self-limiting
• Nausea and vomiting: more common during the first few days of treatment
• Constipation: less common than diarrhoea but still reported
• Flatulence: related to changes in gastric acid production

These side effects are generally mild, transient and do not require stopping the medicine. They affect a small minority of users and tend to resolve within the first 1 to 2 weeks of treatment.

If you are taking esomeprazole for a short course (e.g. 4 weeks for a stomach ulcer), the likelihood of experiencing significant side effects is low.

The BNF recommends using the lowest effective dose for the shortest necessary duration.

The following side effects occur in fewer than 1 in 100 people but are worth being aware of:

Uncommon (1 in 100 to 1 in 1,000):

• Dizziness: usually mild and postural
• Dry mouth: may improve with adequate hydration
• Skin rash or itching: if severe, stop the medicine and seek advice
• Peripheral oedema (swelling of ankles or feet)
• Sleep disturbance: including insomnia, which can sometimes be managed by taking the medicine in the morning
• Paraesthesia (tingling or pins and needles)

Rare (1 in 1,000 to 1 in 10,000):

• Taste disturbance: altered or metallic taste
• Joint pain (arthralgia): reported infrequently
• Blurred vision: rare and usually reversible
• Hepatitis: very rare; liver function tests should be checked if jaundice or unexplained fatigue develops
• Blood disorders: including leucopenia and thrombocytopenia (very rare)

Very rare:

• Stevens-Johnson syndrome and toxic epidermal necrolysis: extremely rare but serious skin reactions. Seek immediate medical attention if you develop widespread blistering.
• Interstitial nephritis: a rare kidney inflammation that may present with fever, rash and abnormal kidney function tests

Report any unusual symptoms to your prescriber and consider reporting via the Yellow Card Scheme.

Long-term PPI use (generally defined as continuous use for more than 8 to 12 weeks) has been associated with several potential risks.

These are the subject of ongoing research, and the absolute risk increase for any individual patient is generally small.

Bone fractures:

• Observational studies have linked long-term PPI use with a modest increase in the risk of hip, wrist and spine fractures
• The MHRA issued a safety update advising that PPIs at high doses or used long-term may be associated with a small increased risk of fracture
• Patients with other osteoporosis risk factors should ensure adequate calcium and vitamin D intake

Hypomagnesaemia (low magnesium):

• Prolonged PPI use can impair magnesium absorption in the gut
• Symptoms include muscle cramps, tremor, palpitations and fatigue
• The BNF recommends measuring magnesium levels if long-term PPI therapy is required, particularly in patients also taking digoxin or diuretics

Clostridium difficile infection:

• Reduced stomach acid may allow C. difficile bacteria to survive passage through the stomach
• The risk is particularly relevant in hospital settings and in older adults

Vitamin B12 deficiency:

• Stomach acid aids vitamin B12 absorption; long-term acid suppression may reduce B12 levels over time
• Annual B12 monitoring may be appropriate for long-term users

Kidney disease:

• Some studies have suggested a link between long-term PPI use and chronic kidney disease, though a definitive causal relationship has not been established

These risks do not mean you should stop esomeprazole without medical advice.

The benefits of treatment often outweigh the risks, particularly for conditions like Barrett's oesophagus or severe reflux oesophagitis.

NICE and NHS England both recommend regular review of ongoing PPI prescriptions to ensure continued need.

When a PPI review is appropriate:

• After the initial treatment course (e.g. 4 to 8 weeks for an ulcer or reflux)
• At your annual medication review
• If your symptoms have resolved
• If you have been on a PPI for more than 12 months without a clear ongoing indication

Indications for long-term PPI use (where stopping may not be appropriate):

• Barrett's oesophagus
• Severe oesophagitis (Los Angeles grade C or D)
• Zollinger-Ellison syndrome
• Concurrent long-term NSAID or antiplatelet therapy in high-risk patients

How to step down or stop:

• Your prescriber may suggest reducing the dose first (e.g. from 40 mg to 20 mg)
• After a period on the reduced dose, switching to "as-needed" use may be appropriate
• Some patients experience rebound acid hypersecretion when stopping a PPI abruptly, leading to a temporary worsening of reflux symptoms. This typically resolves within 2 to 4 weeks
• Antacids (e.g. calcium carbonate, alginate) can be used for symptom relief during the step-down period

Do not stop esomeprazole abruptly without discussing it with your prescriber, particularly if you are taking it for a specific medical condition.

While most esomeprazole side effects are mild, certain symptoms warrant prompt medical attention.

Contact your prescriber if you experience:

• Persistent diarrhoea (especially if watery or containing blood), which may indicate C. difficile infection
• Unexplained muscle cramps, tremor or palpitations (possible hypomagnesaemia)
• Joint pain or skin rash, which may indicate an allergic reaction or a rare autoimmune response (subacute cutaneous lupus erythematosus has been reported with PPIs)
• Persistent or worsening abdominal pain
• Unexplained weight loss or difficulty swallowing (these are "alarm" symptoms that require investigation regardless of PPI use)

Seek urgent medical attention for:

• Severe skin blistering or widespread rash (possible Stevens-Johnson syndrome)
• Signs of a severe allergic reaction: facial swelling, difficulty breathing, throat tightness
• Vomiting blood or passing black, tarry stools (signs of gastrointestinal bleeding)

Important reminder:

If you are taking esomeprazole for dyspepsia and your symptoms do not improve after 4 weeks, or if they return quickly after stopping, your GP may wish to arrange further investigation (e.g.

an upper GI endoscopy) to rule out underlying conditions.